Arcutis Biotherapeutics, Inc. (ARQT)
28.55
-0.42
(-1.45%)
USD |
NASDAQ |
Dec 29, 16:00
28.55
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Enterprise Value: 3.471B for Dec. 26, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CorMedix, Inc. | 935.90M |
| ADMA Biologics, Inc. | 4.610B |
| ANI Pharmaceuticals, Inc. | 2.211B |
| Editas Medicine, Inc. | 124.91M |
| Amicus Therapeutics, Inc. | 4.576B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 7.41M |
| Revenue (Quarterly) | 99.22M |
| Total Expenses (Quarterly) | 91.81M |
| EPS Diluted (Quarterly) | 0.0558 |
| Gross Profit Margin (Quarterly) | 91.25% |
| Profit Margin (Quarterly) | 7.47% |
| Earnings Yield | -1.24% |
| Normalized Earnings Yield | -1.246 |